FLT3 and acute myeloid leukemia: Here the authors combined complementary metabolomics with a CRISPR screen to show that glutamine metabolism, through its ability to support both the TCA cycle and GSH synthesis, becomes a metabolic dependency of FLT3-IDT AML, specifically unmasked by FLT3-TKI treatment.